December 7, 2018
Teva Takeda Yakuhin announced on December 6 that it has applied for a pediatric indication based on information in the public domain for the angiotensin receptor blocker (ARB) Blopress Tablets (candesartan). The Japanese Society of Pediatric Cardiology and Cardiac Surgery...read more